Loading...
Loading...
India's tobramycin imports from TAIWAN total $245 across 1 shipments from 1 foreign suppliers. BORA PHARMACEUTICALS OPHTHALMIC INC. leads with $245 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI. This corridor reflects India's pharmaceutical import demand for tobramycin — a concentrated sourcing relationship with select suppliers from TAIWAN.

BORA PHARMACEUTICALS OPHTHALMIC INC. is the leading Tobramycin supplier from TAIWAN to India, with import value of $245 across 1 shipments. The top 5 suppliers — BORA PHARMACEUTICALS OPHTHALMIC INC. — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BORA PHARMACEUTICALS OPHTHALMIC INC. | $245 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI | $245 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Tobramycin suppliers from TAIWAN to India include BORA PHARMACEUTICALS OPHTHALMIC INC.. The leading supplier is BORA PHARMACEUTICALS OPHTHALMIC INC. with import value of $245 USD across 1 shipments. India imported Tobramycin worth $245 USD from TAIWAN in total across 1 shipments.
India imported Tobramycin worth $245 USD from TAIWAN across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Tobramycin sourced from TAIWAN include ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI. The largest buyer is ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI with $245 in imports across 1 shipments.
The total value of Tobramycin imports from TAIWAN to India is $245 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists